Over the past couple of weeks there have been much discussion and reporting on totally drug-resistant tuberculosis (TDR-TB) based on reports of new cases in India. Here are links to coverage of TDR-TB in India, excerpt from a response by Dr. Nardell who we interviewed last year, and link to the WHO Fact Sheet on TDR-TB. Additional links to TB R&D News are included.
In this week’s TB R&D update, we look at TB as a risk factor for mother-to-child transmission of HIV. The research is published in the February issue of the Journal of Infectious Diseases and is entitled “Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus.” Also, links to additional news in TB R&D are included.
Yesterday, Mario Raviglione , Director of Stop TB, and Giorgio Roscigno, CEO of FIND, held a global press conference announcing the World Health Organization’s endorsement of the new rapid diagnostic test Xpert MTB/RIF. If implemented to scale in countries where tuberculosis (TB) is endemic, it could revolutionize how TB is diagnosed and treated. The test could have a significant impact on patients that are smear negative, HIV positive, or infected with drug-resistant TB.
Even before the recent earthquake shook large portions of Haiti to rubble, the country already had the highest tuberculosis rate in the Americas (roughly 30,000 new cases each year). With the health infrastructure now mostly in ruins, TB is likely to rise even further. The New York Times’ Ian Urbina writes how the country’s sole [...]